hepatocellular carcinoma
Conditions
Interventions
Sponsors
Zhejiang Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Age =18 years old, male or female; 2. Patients with hepatocellular carcinoma who meet the clinical diagnostic criteria of the Chinese Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 edition) and/or have been confirmed by histopathological or cytological examination (CNLC Stage IIa-IIIb); 3. Inoperable patients; 4. According to mRECIST criteria, subjects must have measurable target lesions examined by CT or MRI; 5. Subjects have previously received systemic therapy with Acora monotherapy or combination regimens; 6. Subjects voluntarily participate in this project
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. In the clinician's judgment, the patient is not suitable for inclusion in other conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival, OS;Objective response rate, ORR;Disease Control Rate, DCR;Duration of Response, DoR;Progression-free survival, PFS; | — |
Countries
CHINA
Contacts
Public ContactGUOLIANG SHAO
Zhejiang Cancer Hospital
Outcome results
None listed